406 related articles for article (PubMed ID: 31565001)
1. "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics.
Moscoso CG; Steer CJ
Hepat Med; 2019; 11():109-129. PubMed ID: 31565001
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
3. Reversal of liver cirrhosis: current evidence and expectations.
Jung YK; Yim HJ
Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis.
Garbuzenko DV
World J Clin Cases; 2022 Apr; 10(12):3662-3676. PubMed ID: 35647163
[TBL] [Abstract][Full Text] [Related]
5. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
de Oliveira da Silva B; Ramos LF; Moraes KCM
Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
[TBL] [Abstract][Full Text] [Related]
6. Activation of hepatic stellate cells--a key issue in liver fibrosis.
Reeves HL; Friedman SL
Front Biosci; 2002 Apr; 7():d808-26. PubMed ID: 11897564
[TBL] [Abstract][Full Text] [Related]
7. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
8. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of hepatic stellate cell activation as a therapeutic target for the treatment of non-alcoholic steatohepatitis].
Tsuchida T
Nihon Yakurigaku Zasshi; 2019; 154(4):203-209. PubMed ID: 31597900
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.
Martínez AK; Maroni L; Marzioni M; Ahmed ST; Milad M; Ray D; Alpini G; Glaser SS
Curr Pathobiol Rep; 2014 Dec; 2(4):143-153. PubMed ID: 25396098
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy.
Li D; Friedman SL
J Gastroenterol Hepatol; 1999 Jul; 14(7):618-33. PubMed ID: 10440206
[TBL] [Abstract][Full Text] [Related]
12. New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets.
Santos-Laso A; Munoz-Garrido P; Felipe-Agirre M; Bujanda L; Banales JM; Perugorria MJ
Curr Drug Targets; 2017; 18(8):908-920. PubMed ID: 25915485
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of hepatic fibrosis.
Hui AY; Friedman SL
Expert Rev Mol Med; 2003 Feb; 5(5):1-23. PubMed ID: 14987408
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis.
Barcena-Varela M; Colyn L; Fernandez-Barrena MG
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117267
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.
Nevzorova YA; Hu W; Cubero FJ; Haas U; Freimuth J; Tacke F; Trautwein C; Liedtke C
Biochim Biophys Acta; 2013 Oct; 1832(10):1765-75. PubMed ID: 23770341
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
[TBL] [Abstract][Full Text] [Related]
18. Role of oxidative stress and molecular changes in liver fibrosis: a review.
Sánchez-Valle V; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
Curr Med Chem; 2012; 19(28):4850-60. PubMed ID: 22709007
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis: from the bench to clinical targets.
Pinzani M; Rombouts K
Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
[TBL] [Abstract][Full Text] [Related]
20. Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver.
Gandhi CR
Front Med (Lausanne); 2020; 7():130. PubMed ID: 32373617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
